PUMILIO, but Not RBMX, Binding Is Required for Regulation of Genomic
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Alternative Polyadenylation in Triple-Negative Breast Tumors Allows NRAS and C-JUN to Bypass PUMILIO Post-Transcriptional Regulation
Author Manuscript Published OnlineFirst on October 10, 2016; DOI: 10.1158/0008-5472.CAN-16-0844 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Title: Alternative polyadenylation in triple-negative breast tumors allows NRAS and c-JUN to bypass PUMILIO post-transcriptional regulation Running Title: Alternative polyadenylation in triple-negative breast cancer Authors: Wayne O. Miles 1, 2, 7, Antonio Lembo 3, 4, Angela Volorio 5, Elena Brachtel 5, Bin Tian 6, Dennis Sgroi 5, Paolo Provero 3, 4 and Nicholas J. Dyson 1, 7 1 Department of Molecular Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, 149 13th Street, Charlestown, MA, 02129, USA. 2 Department of Molecular Genetics, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210 3 Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy. 4 Center for Translational Genomics and Bioinformatics, San Raffaele Scientific Institute, Milan, Italy. 5 Pathology Department, Massachusetts General Hospital Cancer Center and Harvard Medical School, 149 13th Street, Charlestown, MA, 02129, USA. 6 Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, Newark, NJ, USA 7 Corresponding authors: [email protected] (N.D.) and [email protected] (W.O.M.) Conflict of interest The authors have no conflict of interest. Financial Support 1 Downloaded from cancerres.aacrjournals.org on September 25, 2021. © 2016 American Association for Cancer Research. Author Manuscript Published OnlineFirst on October 10, 2016; DOI: 10.1158/0008-5472.CAN-16-0844 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. -
Regulation of Pluripotency by RNA Binding Proteins
Cell Stem Cell Review Regulation of Pluripotency by RNA Binding Proteins Julia Ye1,2 and Robert Blelloch1,2,* 1The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, Center for Reproductive Sciences, University of California, San Francisco, San Francisco, CA 94143, USA 2Department of Urology, University of California, San Francisco, San Francisco, CA 94143, USA *Correspondence: [email protected] http://dx.doi.org/10.1016/j.stem.2014.08.010 Establishment, maintenance, and exit from pluripotency require precise coordination of a cell’s molecular machinery. Substantial headway has been made in deciphering many aspects of this elaborate system, particularly with respect to epigenetics, transcription, and noncoding RNAs. Less attention has been paid to posttranscriptional regulatory processes such as alternative splicing, RNA processing and modification, nuclear export, regulation of transcript stability, and translation. Here, we introduce the RNA binding proteins that enable the posttranscriptional regulation of gene expression, summarizing current and ongoing research on their roles at different regulatory points and discussing how they help script the fate of pluripotent stem cells. Introduction RBPs are responsible for every event in the life of an RNA Embryonic stem cells (ESCs), which are derived from the inner molecule, including its capping, splicing, cleavage, nontem- cell mass of the mammalian blastocyst, are remarkable because plated nucleotide addition, nucleotide editing, nuclear export, they can propagate in vitro indefinitely while retaining both the cellular localization, stability, and translation (Keene, 2007). molecular identity and the pluripotent properties of the peri-im- Overall, little is known about RBPs: most are classified based plantation epiblast. -
A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated. -
High-Throughput Discovery of Novel Developmental Phenotypes
High-throughput discovery of novel developmental phenotypes The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Dickinson, M. E., A. M. Flenniken, X. Ji, L. Teboul, M. D. Wong, J. K. White, T. F. Meehan, et al. 2016. “High-throughput discovery of novel developmental phenotypes.” Nature 537 (7621): 508-514. doi:10.1038/nature19356. http://dx.doi.org/10.1038/nature19356. Published Version doi:10.1038/nature19356 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:32071918 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Nature. Manuscript Author Author manuscript; Manuscript Author available in PMC 2017 March 14. Published in final edited form as: Nature. 2016 September 22; 537(7621): 508–514. doi:10.1038/nature19356. High-throughput discovery of novel developmental phenotypes A full list of authors and affiliations appears at the end of the article. Abstract Approximately one third of all mammalian genes are essential for life. Phenotypes resulting from mouse knockouts of these genes have provided tremendous insight into gene function and congenital disorders. As part of the International Mouse Phenotyping Consortium effort to generate and phenotypically characterize 5000 knockout mouse lines, we have identified 410 Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms #Corresponding author: [email protected]. -
RBMX Is a Novel Hepatic Transcriptional Regulator of SREBP-1C Gene Response to High-Fructose Diet
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector FEBS Letters 581 (2007) 218–222 RBMX is a novel hepatic transcriptional regulator of SREBP-1c gene response to high-fructose diet Tadashi Takemotoa, Yoshihiko Nishiob,*, Osamu Sekineb, Chikako Ikeuchib, Yoshio Nagaib, Yasuhiro Maenob, Hiroshi Maegawab, Hiroshi Kimuraa, Atsunori Kashiwagib a Division of Molecular Genetics in Medicine, Department of Biochemistry and Molecular Biology, Shiga University of Medical Science, Shiga 520-2192, Japan b Division of Endocrinology and Metabolism, Department of Medicine, Shiga University of Medical Science, Shiga 520-2192, Japan Received 24 October 2006; accepted 1 December 2006 Available online 14 December 2006 Edited by Berend Wieringa nisms by which the high-fructose diet induces SREBP-1c gene Abstract In rodents a high-fructose diet induces metabolic derangements similar to those in metabolic syndrome. Previously expression in the liver. we suggested that in mouse liver an unidentified nuclear protein We previously reported a variation of susceptibility to these binding to the sterol regulatory element (SRE)-binding protein- metabolic disorders after monitoring the effects of high-fruc- 1c (SREBP-1c) promoter region plays a key role for the re- tose diet in different mouse strains [6]. Ten strains of inbred sponse to high-fructose diet. Here, using MALDI-TOF MASS mice were separated into CBA and DBA groups according technique, we identified an X-chromosome-linked RNA binding to their response to high-fructose diet. The hepatic mRNA motif protein (RBMX) as a new candidate molecule. In electro- expression of SREBP-1c in CBA/JN mice was remarkably ele- phoretic mobility shift assay, anti-RBMX antibody displaced the vated by high-fructose diet but not in DBA/2N. -
PUM1 Represses CDKN1B Translation and Contributes to Prostate Cancer
medRxiv preprint doi: https://doi.org/10.1101/2021.05.27.21257930; this version posted May 30, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . 1 PUM1 represses CDKN1B translation and contributes to prostate cancer 2 progression 3 4 Running title: Translational regulation of prostate cancer 5 6 Xin Li1#, Jian Yang1, 2#, Xia Chen1, Dandan Cao1 and Eugene Yujun Xu1,3* 7 8 1State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, 9 211166, China 10 2 Urology Department, The Second Affiliated Hospital of Nanjing Medical University, 11 Nanjing, 211166, China 12 3 Department of Neurology, Feinberg School of Medicine, Northwestern University 13 # Equal contribution 14 Contact: Dr. Eugene Y Xu [email protected] 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. 30 medRxiv preprint doi: https://doi.org/10.1101/2021.05.27.21257930; this version posted May 30, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . 31 Abstract 32 Posttranscriptional regulation of cancer gene expression programs plays a vital role 33 in carcinogenesis; identifying the critical regulators of tumorigenesis and their 34 molecular targets may provide novel strategies for cancer diagnosis and therapeutics. -
Structural Basis for Specific Recognition of Multiple Mrna Targets by a PUF Regulatory Protein
Structural basis for specific recognition of multiple mRNA targets by a PUF regulatory protein Yeming Wanga, Laura Oppermanb, Marvin Wickensb,1, and Traci M. Tanaka Halla,1 aLaboratory of Structural Biology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709; and bDepartment of Biochemistry, University of Wisconsin, Madison, WI 53706 Edited by Keith R. Yamamoto, University of California, San Francisco, CA, and approved October 2, 2009 (received for review December 2, 2008) Caenorhabditis elegans fem-3 binding factor (FBF) is a founding association in worm extracts, immunocytochemistry, and genetics member of the PUMILIO/FBF (PUF) family of mRNA regulatory (5, 8, 23–27). FBF is required for maintenance of germline stem proteins. It regulates multiple mRNAs critical for stem cell mainte- cells, a conserved function of PUF proteins (1). FBF maintains stem nance and germline development. Here, we report crystal struc- cells by repressing the expression of differentiation regulators, tures of FBF in complex with 6 different 9-nt RNA sequences, including gld-1, fog-1, lip-1, and mpk-1 (28). In addition, FBF including elements from 4 natural mRNAs. These structures reveal regulates the switch from spermatogenesis to oogenesis by repress- that FBF binds to conserved bases at positions 1–3 and 7–8. The key ing fem-3 mRNA (8). The regulatory elements found in the specificity determinant of FBF vs. other PUF proteins lies in posi- different mRNAs are related, but distinct. PUF proteins coimmu- tions 4–6. In FBF/RNA complexes, these bases stack directly with noprecipitate with many mRNAs in yeast, fly, and human extracts one another and turn away from the RNA-binding surface. -
Spinocerebellar Ataxia: an Update
Journal of Neurology (2019) 266:533–544 https://doi.org/10.1007/s00415-018-9076-4 NEUROLOGICAL UPDATE Spinocerebellar ataxia: an update Roisin Sullivan1 · Wai Yan Yau1 · Emer O’Connor1 · Henry Houlden1 Received: 27 July 2018 / Revised: 21 September 2018 / Accepted: 25 September 2018 / Published online: 3 October 2018 © The Author(s) 2018 Abstract Spinocerebellar ataxia (SCA) is a heterogeneous group of neurodegenerative ataxic disorders with autosomal dominant inheritance. We aim to provide an update on the recent clinical and scientific progresses in SCA where numerous novel genes have been identified with next-generation sequencing techniques. The main disease mechanisms of these SCAs include toxic RNA gain-of-function, mitochondrial dysfunction, channelopathies, autophagy and transcription dysregulation. Recent stud- ies have also demonstrated the importance of DNA repair pathways in modifying SCA with CAG expansions. In addition, we summarise the latest technological advances in detecting known and novel repeat expansion in SCA. Finally, we discuss the roles of antisense oligonucleotides and RNA-based therapy as potential treatments. Keywords Spinocerebellar ataxia · Molecular diagnosis · Next-generation sequencing Introduction What is new in the epidemiology of SCA and its subtypes? The Spinocerebellar ataxias (SCA) are a subset of hereditary cerebellar ataxias that are autosomal dominantly transmitted. A recent systemic review shows that the global prevalence of They are progressive neurodegenerative diseases that share SCA is 3 in 100,000 [2], however, a wide regional variation the clinical features of ataxia, which arise from the pro- exists. SCA3 is commonest subtype around the globe [3–5], gressive degeneration of the cerebellum but can also affect SCA2 is more prevalent in Cuba than SCA3 whilst SCA7 other connected regions, including the brain stem. -
A 5 Cytosine Binding Pocket in Puf3p Specifies Regulation Of
A5 cytosine binding pocket in Puf3p specifies regulation of mitochondrial mRNAs Deyu Zhua,1, Craig R. Stumpfb,1, Joseph M. Krahna, Marvin Wickensb,2, and Traci M. Tanaka Halla,2 aLaboratory of Structural Biology, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709; and bDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706 Edited by Keith R. Yamamoto, University of California, San Francisco, CA, and approved October 2, 2009 (received for review November 26, 2008) A single regulatory protein can control the fate of many mRNAs biological importance of the RNA base at the Ϫ2 position for with related functions. The Puf3 protein of Saccharomyces cerevi- regulation in vivo. siae is exemplary, as it binds and regulates more than 100 mRNAs that encode proteins with mitochondrial function. Here we eluci- Results date the structural basis of that specificity. To do so, we explore the General Puf3p Architecture and the Core Region. Crystal structures crystal structures of Puf3p complexes with 2 cognate RNAs. The key of the RNA-binding domain of Puf3p in complex with the determinant of Puf3p specificity is an unusual interaction between COX17 mRNA sequences for binding site A, CUUGUAUAUA, a distinctive pocket of the protein with an RNA base outside the and site B, CCUGUAAAUA (Fig. 1A), were determined at a ‘‘core’’ PUF-binding site. That interaction dramatically affects bind- resolution of 3.2 and 2.5 Å, respectively. Puf3p interacts with the ing affinity in vitro and is required for regulation in vivo. The Puf3p 8 bases of COX17 mRNA starting from the conserved UGUA structures, combined with those of Puf4p in the same organism, sequence much as human Pumilio1 (PUM1) binds to the equiv- illuminate the structural basis of natural PUF-RNA networks. -
A Divergent Pumilio Repeat Protein Family for Pre-Rrna Processing and Mrna Localization
A divergent Pumilio repeat protein family for pre-rRNA processing and mRNA localization Chen Qiua, Kathleen L. McCannb, Robert N. Winea, Susan J. Basergab,c,d,1, and Traci M. Tanaka Halla,1 aEpigenetics and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709; and Departments of bGenetics, cMolecular Biophysics and Biochemistry, and dTherapeutic Radiology, Yale University School of Medicine, New Haven, CT 06520 Edited by David Baker, University of Washington, Seattle, WA, and approved November 19, 2014 (received for review April 25, 2014) Pumilio/feminization of XX and XO animals (fem)-3 mRNA-binding cell (15). In addition to these functional differences, it is unclear factor (PUF) proteins bind sequence specifically to mRNA targets how these new PUM repeat proteins would interact with target using a single-stranded RNA-binding domain comprising eight RNA. For example, only six PUM repeats are predicted in Puf-A Pumilio (PUM) repeats. PUM repeats have now been identified in and Puf6, and their RNA base-interacting residues are poorly proteins that function in pre-rRNA processing, including human conserved. Puf-A and yeast Puf6. This is a role not previously ascribed to PUF Vertebrate Puf-A functions appear to be important for diseases proteins. Here we present crystal structures of human Puf-A that and embryonic development, but more knowledge is needed to reveal a class of nucleic acid-binding proteins with 11 PUM repeats connect vertebrate morbidities with molecular mechanisms. Human arranged in an “L”-like shape. In contrast to classical PUF proteins, Puf-A changes localization from predominantly nucleolar to nu- Puf-A forms sequence-independent interactions with DNA or RNA, clear when cells are treated with transcriptional or topoisomerase mediated by conserved basic residues. -
Coding RNA Genes
Review A guide to naming human non-coding RNA genes Ruth L Seal1,2,* , Ling-Ling Chen3, Sam Griffiths-Jones4, Todd M Lowe5, Michael B Mathews6, Dawn O’Reilly7, Andrew J Pierce8, Peter F Stadler9,10,11,12,13, Igor Ulitsky14 , Sandra L Wolin15 & Elspeth A Bruford1,2 Abstract working on non-coding RNA (ncRNA) nomenclature in the mid- 1980s with the approval of initial gene symbols for mitochondrial Research on non-coding RNA (ncRNA) is a rapidly expanding field. transfer RNA (tRNA) genes. Since then, we have worked closely Providing an official gene symbol and name to ncRNA genes brings with experts in the ncRNA field to develop symbols for many dif- order to otherwise potential chaos as it allows unambiguous ferent kinds of ncRNA genes. communication about each gene. The HUGO Gene Nomenclature The number of genes that the HGNC has named per ncRNA class Committee (HGNC, www.genenames.org) is the only group with is shown in Fig 1, and ranges in number from over 4,500 long the authority to approve symbols for human genes. The HGNC ncRNA (lncRNA) genes and over 1,900 microRNA genes, to just four works with specialist advisors for different classes of ncRNA to genes in the vault and Y RNA classes. Every gene symbol has a ensure that ncRNA nomenclature is accurate and informative, Symbol Report on our website, www.genenames.org, which where possible. Here, we review each major class of ncRNA that is displays the gene symbol, gene name, chromosomal location and currently annotated in the human genome and describe how each also includes links to key resources such as Ensembl (Zerbino et al, class is assigned a standardised nomenclature. -
Role of the Post-Transcriptional Regulators Pumilio1 and Pumilio2 in Murine Hematopoietic Stem Cells Fabio Michelet
Role of the post-transcriptional regulators Pumilio1 and Pumilio2 in murine hematopoietic stem cells Fabio Michelet To cite this version: Fabio Michelet. Role of the post-transcriptional regulators Pumilio1 and Pumilio2 in murine hematopoietic stem cells. Human health and pathology. Université René Descartes - Paris V, 2013. English. NNT : 2013PA05S013. tel-00911665 HAL Id: tel-00911665 https://tel.archives-ouvertes.fr/tel-00911665 Submitted on 29 Nov 2013 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Université Paris Descartes Ecole Doctorale Biologie et Biotechnologie INSERM U1016, Institut Cochin / Equipe Dusanter-Cramer Role of the post-transcriptional regulators Pumilio1 and Pumilio2 in murine Hematopoietic Stem Cells Par Fabio Michelet Thèse de doctorat en Hématologie et Oncologie Dirigée par Dr. Evelyne Lauret Présentée et soutenue publiquement le 7 Novembre 2013 Devant un jury composé de : Président: Pr. Lacombe Catherine (PU-PH) Rapporteur: Dr. Simonelig Martine (DR2). Rapporteur: Dr. Mazurier Frédéric (DR2) Examinateur: Dr. Cohen-Tannoudji